Nkarta, Inc. logo

Nkarta, Inc.

NASDAQ:NKTX

Overview | Financials
Company Name Nkarta, Inc.
Symbol NKTX
Currency USD
Price 6.01
Market Cap 423,510,276
Dividend Yield 0%
52-week-range 1.28 - 16.24
Industry Biotechnology
Sector Healthcare
CEO Mr. Paul J. Hastings
Website https://www.nkartatx.com

An error occurred while fetching data.

About Nkarta, Inc.

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface

Related Stocks

ZimVie Inc. logo

ZimVie Inc.

ZIMV

15.71 USD

iTeos Therapeutics, Inc. logo

iTeos Therapeutics, Inc.

ITOS

16.23 USD

Quanterix Corporation logo

Quanterix Corporation

QTRX

13.32 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

5.08 USD

Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

ATAI

1.37 USD

Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

AVIR

3.61 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

5.74 USD

Financials

Numbers are in millions USD

Numbers are in millions USD